This website uses cookies to enhance the user experience.
A

ARISTEIA AS916 639 759

Research
Limited company
Aristeia AS Oslo Science Park Gaustadalléen 21 0349 OSLO, Norge

ARISTEIA AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
8 years
since Feb 4, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
3,006
1 share class
Total number of shareholders
26
19 companies, 7 persons

Financials

Annual total result 2023
152,800
NOK
Total equity 2023
7,384,006
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
40.39 %
directly

Board

NameRoleShares
Chairman-
Board Member
40.39 %
directly

Others

NameRoleShares
O
ON TIME REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Board Member
40.39 %
directly
KB
-
3.56 %
indirectly
-
2.76 %
indirectly
-
2.73 %
indirectly
-
2.44 %
indirectly
-
2.1 %
indirectly
-
1.63 %
indirectly
-
1.63 %
indirectly
-
1.43 %
indirectly
-
1.43 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
1,214
40.39 %
L
LEIV EIRIKSSON NYSKAPING AS
Ordinary shares
601
19.99 %
A
AC INVESTORS AS
Ordinary shares
198
6.59 %
A
ALEAP AS
Ordinary shares
183
6.09 %
A
AKER BYGG AS
Ordinary shares
164
5.46 %
N
NEGASSIE HOLDING AS
Ordinary shares
86
2.86 %
M
MONEY PENNY AS
Ordinary shares
82
2.73 %
H
HERMITAGE HOLDING AS
Ordinary shares
64
2.13 %
A
AHAN AS
Ordinary shares
63
2.1 %
S
SAVOCA AS
Ordinary shares
41
1.36 %
T
TRECA AS
Ordinary shares
41
1.36 %
M
M. SVELA HOLDING AS
Ordinary shares
35
1.16 %
G
GACA AS
Ordinary shares
34
1.13 %
S
SCHANDERS FORVALTNING AS
Ordinary shares
30
1 %
R
RIFA AS
Ordinary shares
24
0.8 %
B
BCH AS
Ordinary shares
24
0.8 %
Ordinary shares
17
0.57 %
T
TITTENTEI AS
Ordinary shares
16
0.53 %
Ordinary shares
16
0.53 %
Ordinary shares
14
0.47 %
HC
Ordinary shares
13
0.43 %
F
FINEFRONT INVEST AS
Ordinary shares
10
0.33 %
W
Ordinary shares
10
0.33 %
Ordinary shares
10
0.33 %
P
PHARMORE AS
Ordinary shares
10
0.33 %
Ordinary shares
6
0.2 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
2,414,573
881,500
Annual Total Result
152,800
-51,441
-4,508,056
Total assets
7,661,577
7,584,385
5,006,267
Total liabilities
277,570
353,179
1,204,260
Total equity
7,384,006
7,231,206
3,802,007

P&L

Year202320222021
Total operating income
0
2,414,573
881,500
Total operating costs
191,753
3,074,727
5,778,174
Operating result
-191,753
-660,154
-4,896,674
Financial income/costs
24,489
42,332
14,022
Profit before tax
-167,264
-617,822
-4,882,652
Total tax & extraordinary income/cost
-320,064
-566,381
-374,596
Annual Total Result
152,800
-51,441
-4,508,056

Balance overview

Year202320222021
Total fixed assets
6,919,697
5,555,213
0
Total current assets
741,880
2,029,172
5,006,267
Total assets
7,661,577
7,584,385
5,006,267
Short term debt
277,570
353,179
1,204,260
Long term debt
0
0
0
Total liabilities
277,570
353,179
1,204,260
Contributed capital
11,617,736
11,617,736
11,617,736
Retained earnings
-4,233,730
-4,386,530
-7,815,729
Total equity
7,384,006
7,231,206
3,802,007
Total equity and liabilities
7,661,577
7,584,385
5,006,267

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering